Biography and Research Information
OverviewAI-generated summary
Mahesh Bavineni's research investigates cardiovascular diseases and their risk factors. His work has explored the relationship between HDL cholesterol levels and susceptibility to COVID-19, with publications in 2022 examining this association. Bavineni also contributes to the study of heart failure, focusing on renal biomarkers and the prognostic role of serum cystatin C, as evidenced by a systematic review and meta-analysis published in 2023. His collaborations at the University of Arkansas for Medical Sciences include shared publications with Subhi J. Al’Aref and Jawahar L. Mehta. Bavineni has authored 11 publications with a total of 171 citations and an h-index of 4.
Metrics
- h-index: 4
- Publications: 11
- Citations: 175
Selected Publications
-
Renal Biomarkers in Heart Failure (2024)
-
Prognostic Role Of Serum Cystatin C In Heart Failure: Systematic Review And Meta-analysis (2023)
-
HDL cholesterol levels and susceptibility to COVID-19 (2022)
-
Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection (2022)
-
Premature birth, infections, and atherosclerotic cardiovascular disease (2019)
-
Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood (2019)
-
Improved stent expansion with prolonged compared with short balloon inflation: A meta‐analysis (2018)
-
Atherosclerosis and Gender-Related Differences (2018)
-
MAGNITUDE OF IMPROVED STENT EXPANSION WITH PROLONGED STENT BALLOON INFLATION: A META-ANALYSIS (2018)
Collaboration Network
Top Collaborators
- HDL cholesterol levels and susceptibility to COVID-19
- Renal Biomarkers in Heart Failure
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- Prognostic Role Of Serum Cystatin C In Heart Failure: Systematic Review And Meta-analysis
- HDL cholesterol levels and susceptibility to COVID-19
- Renal Biomarkers in Heart Failure
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- Prognostic Role Of Serum Cystatin C In Heart Failure: Systematic Review And Meta-analysis
- HDL cholesterol levels and susceptibility to COVID-19
- Renal Biomarkers in Heart Failure
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
- Renal Biomarkers in Heart Failure
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- Renal Biomarkers in Heart Failure
- Prognostic Role Of Serum Cystatin C In Heart Failure: Systematic Review And Meta-analysis
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
Similar Researchers
Based on overlapping research topics